Agency for Science, Technology and Research (A*STAR). Cancer Therapeutics and Stratified Oncology ^{R&D Centre}

Key areas of strength involve the identification of synthetic lethal gene-gene interactions, genomic alterations related to patient clinical outcome, and the development of novel strategies for cancer therapy.